SECTION I: ESTIMATION OF COSTS
|
1 |
Taking into account the rest of the cost evaluation please provide an overall estimation of the total costs for full deployment/production of the R & D result. |
||||||||
|
… in terms of IPR protection |
|||||||||
|
License file application 700 euros, maintenance 350 euros/year |
|||||||||
|
…in terms of product development |
|||||||||
Total is 90.000
|
|||||||||
|
…in terms of mass production |
|||||||||
|
There are no mass production costs |
|||||||||
|
… in terms of marketing |
|||||||||
|
The product yields a major marketing campaign. In the first year a major marketing effort will be made to target markets mainly using web-marketing resources. The effort will include monthly free trial use and will involve social media marketing. The cost of marketing cost for second year is 50.000 euro, while the subsequent years is limited to 10.000 euros per year. |
|||||||||
|
2 |
Based on the above assessment as well as the marketing information please provide the correct estimation of the price for R&D product in correlation with costs |
||||||
|
|
Year 1 |
Year 2 |
Year 3 |
Year 4 |
Year 5 |
|
|
|
Fixed costs |
20,000 |
25,000 |
30,000 |
35,000 |
40,000 |
|
|
|
Personnel |
90,000 |
45,000 |
81,000 |
112,500 |
157,500 |
|
|
|
Other running costs |
4,500 |
15,000 |
27,000 |
37,500 |
52,500 |
|
|
|
Marketing costs |
50000 |
10,000 |
10,000 |
10,000 |
10,000 |
|
|
|
TOTAL EXPECTED COSTS |
164,500 |
95,000 |
148,000 |
195,000 |
260,000 |
|
|
|
Price per Unit |
15000 |
15000 |
15000 |
15000 |
15000 |
|
|
|
Number of Units |
3 |
10 |
18 |
25 |
35 |
|
|
|
TOTAL Expected Revenues |
45,000 |
150,000 |
270,000 |
375,000 |
525,000 |
|
|
|
CASH FLOW REQUIRED (REVENUES-COSTS) |
-119,500 |
55,000 |
122,000 |
180,000 |
265,000 |
|
|
|
TOTAL CAPITAL required for five years |
Total required capital = 119.500 |
|
|||||
SECTION 2: QUALITATIVE FACTORS
|
3 |
Dimension of identified target groups |
Targets groups for Web site administration, RDC creators, be marketed through web marketing. The number of web sites 555 million (December 2011), giving a rise of 29.5 million (+5.6%) since last month.. the analysis is overwhelming but targets are set to moderate 200 contracts for the second year, 300 for third after marketing campaign, 350 for the fourth year and 500 after four years of operations.
|
4 |
Evaluation of financial Risks for R&D result |
|
The project is considered low risk since the tool has been already developed and tested.. |
|
SECTION 3: IDENTIFICATION OF FINANCING SOURCES
After evaluating all the above mentioned criteria, please tick the best financing source for the achievement of R&D result (i.e. own capitals, banking credits, venture capital, business angels, etc)
|
1. European Funding Define relevance of the product with the following potential funding sources and comment |
|
FP7 related ICT |
|
2.National Funding |
|
GSRT programmes |
|
3. Private funding |
|
Jeremie and venture capital funds |
|
4. Other |
|
|
SECTION 3: FINAL EVALUATION
|
It is requested a final evaluation considering the funding opportunities you believe most suitable for the exploitation of the R&D result, considering the possibility of the creation of a spin-off, further research, in particular, a cost/benefit analysis and a financial projection for the R&D result, type of collaboration identified (i.e. Licensing Agreement, Technical Cooperation, Joint Venture, Manufacturing Agreement, Commercial Agreement with Technical Assistance, Creation of a spin-off, Joint further development)… |
|
A private-public partnership schema could be developed to finance the launching of the product to the market, in terms of a joint venture. |
Decision of evaluation (Please keep only the appropriate)
The R&D has a high potential.
Nikos Zaharis
